August 20, 2024 - Novel technologies that seek to improve quality of life or simplify complex processes offer great promise. For example, medical technologies that detect or cure disease or supply ...

Clinicians can simulate therapy responses using digital twins to predict treatment outcomes and adjust care plans in a controlled virtual environment.

Virtonomy’s digital twin technology can help enhance medical device design in a virtual patient setting, accelerating development timelines and reducing costs, risk, and regulatory barriers.

Other examples, described in a March Nature Computational Science report I co-authored, include a digital twin for the treatment of cardiac arrythmias and treatment optimization for breast cancer ...

For example, for a high-rise building, with a digital twin, we can identify minor structural issues and implement them in the virtual world before carrying them over to the real world, cutting ...

Nvidia has been a leader in providing AI and digital twin infrastructure for the medical community.Its various offerings improve diagnostics, the development of new medical devices, medical ...

For example, Uber’s digital twin will have virtual cars and drivers, with virtual subscribers requesting services. It is built/programmed using the real-world subscriber and usage data from Uber ...

Perhaps the biggest incentive for drug and device manufacturers to supplement clinical trials with AI digital twins is how it reduces the time it takes, which translates into big cost savings, too.

A digital psychological twin, trained on a person’s medical data and digital footprint, could potentially act as a better surrogate than, for example, a relative who doesn’t know the person ...

The most notable example is Alya Red, a digital twin of a heart comprising around 100 million virtual cells. The heart beats not within a person but inside MareNostrum , one of the most powerful ...

Virtonomy’s digital twin technology can help enhance medical device design in a virtual patient setting, accelerating development timelines and reducing costs, risk, and regulatory barriers.